Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
AGL · against 418 other Healthcare companies of similar size
Ranked #167 of 419 · scores higher than 59% of peers
Bars: peers in each 10-point band of the growth score51 peers with a growth score of 60–69, including AGL · Click a bar to see the companies
Mainly thanks to its 3-year revenue growth, which is stronger than most Healthcare peers.
| Metric | AGL | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 423 reported | 0.3% | 5.5% | 32% | 33% | |
| Earnings per share growthHigher is better · 229 reported | Not reported | 8.3% | — | — | 33% |
| 3-year revenue growthHigher is better · 411 reported | 22.9% | 6.6% | 81% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 8.9B HKD (≈$1.1B) | 99 | 61 | |
| 1 | 1.4B USD | 99 | 73 | |
| 1 | 27.6B SEK (≈$2.8B) | 99 | 76 | |
| 1 | 2.1B USD | 99 | 96 | |
| 1 | 2.8B USD | 99 | 51 | |
| 161 | 11.1B BRL (≈$2.0B) | 63 | 60 | |
| 161 | 1.6B USD | 63 | 24 | |
| 167 | 8.2B CNY (≈$1.2B) | 62 | 50 | |
| 167 | 2.05T KRW (≈$1.5B) | 62 | 81 | |
| 167 | 1.5B USD | 62 | 26 | |
| 167 | 40.2B MXN (≈$2.2B) | 62 | 71 | |
| 167 | 1.9B NZD (≈$1.1B) | 62 | 42 | |
| 167 | 781M EUR (≈$859M) | 62 | 64 | |
| 167 | 14.41T IDR (≈$893M) | 62 | 69 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score